Search Within

Joachim Yahalom

Formats
  1. Journal Article (281)
  2. Meeting Abstract (243)
  3. Book Section (67)
  4. Review (9)
  5. Conference Paper (6)
  6. Research Letter (6)
  7. Guidelines (5)
  8. Correspondence (4)
  9. Editorial (3)
  10. Book Whole (1)
Groups
  1. Radiation Oncology, Department of (625)
  2. Survivorship Research (625)
  3. Department of Medicine (283)
  4. Hematologic Malignancies, Division of (277)
  5. Center for Hematologic Malignancies (248)
  6. Lymphoma (205)

More Groups

People
  1. Andrew Zelenetz (116)
  2. Brandon Imber (116)
  3. Craig Moskowitz (87)
  4. David Straus (82)
  5. Carla Hajj (73)
  6. Ariela Noy (71)

More People

Years
  1. 2025 (9)
  2. 2024 (26)
  3. 2023 (48)
  4. 2022 (26)
  5. 2021 (25)
  6. 2020 (24)

More Years

Publications
  1. International Journal of Radiation Oncology, Biology, Physics (125)
  2. Blood (96)
  3. Journal of Clinical Oncology (46)
  4. Hematological Oncology (34)
  5. Journal of the National Comprehensive Cancer Network (31)
  6. Leukemia and Lymphoma (17)

More Publications

Publishers
  1. Elsevier Inc. (161)
  2. American Society of Hematology (105)
  3. American Society of Clinical Oncology (46)
  4. Wiley Blackwell (43)
  5. Harborside Press (31)
  6. Lippincott Williams & Wilkins (28)

More Publishers

Results (625)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • High complete response rate observed with second-line chemo-immunotherapy with pembrolizumab and GVD (gemcitabine, vinorelbine, and liposomal doxorubicin) in relapsed and refractory classical Hodgkin lymphoma
    Meeting Abstract

    Moskowitz, A. J.; Shah, G. L.; Schoder, H.; Hancock, H.; Davey, T.; Joong, C.; Pomerantz, L.; Jarjies, C.; Kumar, A.; Lahoud, O. B.; more...
    Blood (2019)

    Fulltext@MSK | Save
  • A pilot study of brentuximab vedotin combined with AVD chemotherapy and radiotherapy in patients with newly diagnosed early stage, unfavorable risk Hodgkin lymphoma
    Meeting Abstract

    Kumar, A.; Casulo, C.; Advani, R. H.; Budde, L. E.; Barr, P. M.; Batlevi, C. L.; Caron, P.; Constine, L. S.; Dandapani, S.; Drill, E.; more...
    Blood (2019)

    Fulltext@MSK | Save
  • Early experience using radiotherapy as a salvage treatment for relapsed or refractory non-Hodgkin lymphomas following CD19 chimeric antigen receptor modified T-cell therapy
    Meeting Abstract

    Imber, B.; Palomba, M. L.; DeSelm, C.; Dahi, P. B.; Sauter, C. S.; Scordo, M.; Batlevi, C. L.; Park, J. H.; Shah, G. L.; Giralt, S. A.; more...
    Blood (2019)

    Fulltext@MSK | Save
  • MSKCC early experience using radiotherapy as a bridging strategy for relapsed diffuse large B cell lymphoma before CD19 CAR T therapy
    Meeting Abstract

    Imber, B.; Palomba, M. L.; DeSelm, C.; Batlevi, C. L.; Dahi, P. B.; Giralt, S. A.; Noy, A.; Park, J. H.; Sauter, C. S.; Scordo, M.; more...
    Blood (2019)

    Fulltext@MSK | Save
  • Should a bulky mediastinal mass ≥7cm in the longest dimension be considered an adverse prognostic factor in patients with advanced Hodgkin lymphoma and negative interim PET/CT?
    Meeting Abstract

    Dann, E. J.; Lopez-Alonso, R.; Qi, S.; Mashiach, T.; Weiler-Sagie, M.; Yahalom, J.
    Blood (2019)

    Fulltext@MSK | Save
  • Outcomes of 210 patients with follicular and marginal zone lymphomas treated with 4 Gy of radiation therapy
    Meeting Abstract

    Chau, K.; Imber, B.; Joffe, E.; Yang, J. C.; Chelius, M.; Doyle, C.; Hajj, C.; Yahalom, J.
    Blood (2019)

    Fulltext@MSK | Save
  • Longitudinal cognitive assessment in patients with primary CNS lymphoma treated with induction chemotherapy followed by reduced-dose whole-brain radiotherapy or autologous stem cell transplantation
    Journal Article

    Correa, D. D.; Braun, E.; Kryza-Lacombe, M.; Ho, K. W.; Reiner, A. S.; Panageas, K. S.; Yahalom, J.; Sauter, C. S.; Abrey, L. E.; DeAngelis, L. M.; more...
    Journal of Neuro-Oncology (2019)

    Fulltext@MSK | Save
  • Assessment of lymphoma and other hematologic malignancies training needs amongst radiation oncology residents
    Meeting Abstract

    Kahn, J.; Gunther, J. R.; Yang, J. C.; Yahalom, J.; Dabaja, B.; Vapiwala, N.; Hoppe, B. S.; Tseng, Y. D.; Parikh, R. R.; Plastaras, J. P.
    International Journal of Radiation Oncology, Biology, Physics (2019)

    Fulltext@MSK | Save
  • Practice patterns in early stage Hodgkin lymphoma: Analysis of the National Cancer Database
    Meeting Abstract

    Shah, B. A.; Wu, S. P. P.; Oh, C.; Yahalom, J.; Grossbard, M.; Gerber, N. K.
    International Journal of Radiation Oncology, Biology, Physics (2019)

    Fulltext@MSK | Save
  • Grade 3A follicular lymphoma can be effectively controlled with very low dose radiation therapy
    Meeting Abstract

    Imber, B. S.; Chau, K.; Goldberg, E.; Joffe, E.; Yahalom, J.
    Hematological Oncology (2019)

    Fulltext@MSK | Save